Not recommended for routine detection of Chlamydia trachomatis (CT). Use to detect CT in medicolegal settings and to assess suspected treatment failure. May be considered for anatomic locations for which amplified testing has not been validated.
New York DOH Approval Status
Cervical, eye, rectal, urethral swab, or peritoneal fluid. Also acceptable for newborns: Nasopharyngeal aspirate, swab or washing.
Immediately place swab, fluid, or washing in 3 mL universal transport medium such as M4, M4RT, M5, M6, UniTranz-RT, or UTM (ARUP supply #12884). Available online through eSupply using ARUP Connect or contact ARUP Client Services at (800) 522-2787.
Frozen on dry ice.
Urine. Specimens in any transport media other than indicated. Calcium alginate, dry, or wood swabs.
Specimen source preferred.
Ambient: 1 hour; Refrigerated: 48 hours; Frozen at -20°C: Unacceptable; Frozen at -70°C: 1 month
Culture negative for Chlamydia trachomatis.
Nucleic acid amplification testing is recommended for detection of Chlamydia trachomatis from endocervical or urethral specimens. Refer to Chlamydia trachomatis by Transcription-Medicated Amplification (TMA) (ARUP test code 0060243). Specimen must be collected and transported with test-specific kit (ARUP supply #55224).
Positive Chlamydia cultures are confirmed for trachomatis by Chlamydia trachomatis by Transcription-Mediated Amplification (TMA) at no additional charge. Some specimen types acceptable for the Chlamydia trachomatis Culture may require a disclaimer for the TMA confirmation assay.
|Component Test Code*||Component Chart Name||LOINC|
|0060859||C. trachomatis Culture||6349-5|
|0060865||C. trachomatis Source||31208-2|
- C. Trachomatis
- Chlamydia Trachomatis